Abstract
The goal of this session is to obtain preliminary evidence to support the concurrent validity of the Impairment Rating Scale (IRS) and PROMIS® Parent Proxy Scale version—Global Health 7 (PROMIS® GH-7) measures in participants ages 5–17 years with a diagnosis of ASD. We hypothesized that more severe ASD, as measured by the Social Responsiveness Scale, Second Edition (SRS-2), would be associated with higher scores on the IRS and lower scores on the PROMIS® GH-7.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
